Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit [Yahoo! Finance]
Talphera, Inc. (TLPH)
Company Research
Source: Yahoo! Finance
SAN MATEO, Calif. Oct. 8, 2024 October 15-17, 2024 Event: 2024 Maxim Healthcare Virtual Summit Date: October 16, 2024 Time: 3:00 PM ET Noon PT About Talphera, Inc. Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA). This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com View original content to download multimedia: https://www.prnewswire.com/news-releases/talphera-to-participate-in-fireside-chat-at-the-2024-maxim-healthcare-virtual-summit-302270671.html SOURCE Talphera, Inc. R
Show less
Read more
Impact Snapshot
Event Time:
TLPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TLPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TLPH alerts
High impacting Talphera, Inc. news events
Weekly update
A roundup of the hottest topics
TLPH
News
- Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors [Yahoo! Finance]Yahoo! Finance
- Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive DirectorsPR Newswire
- Talphera Inc (TLPH) Q3 2024 Earnings Call Highlights: Strategic Advances and Financial Challenges [Yahoo! Finance]Yahoo! Finance
- Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate UpdatePR Newswire
- Talphera, Inc. (NASDAQ: TLPH) was upgraded by analysts at Maxim Group to a "strong-buy" rating.MarketBeat
TLPH
Earnings
- 11/13/24 - Beat
TLPH
Analyst Actions
- 11/12/24 - Maxim Group
TLPH
Sec Filings
- 12/11/24 - Form 8-K
- 12/6/24 - Form 4
- 12/2/24 - Form 4
- TLPH's page on the SEC website